Facebook
Twitter
LinkedIn
Forward
Active Surveillance and Management of Prostate Cancer
Activity description
Early-stage prostate cancer, which is confined to the prostate gland, grows slowly and has a five-year survival rate of approximately 99 percent. Early detection and diagnosis can have a significant impact on prognosis and quality of life; however, questions still exist regarding the best approach to screening and active surveillance of this disease. This activity will provide an overview of the natural history of early-stage prostate cancer and review current data on the benefits and drawbacks of screening. It will discuss important aspects of diagnosis and describe evidence-based strategies for detection of early-stage prostate cancer.
PLEASE NOTE: These materials are intended ONLY for those who attended the live webcast held on March 8, 2023 from 6:00-7:00 pm ET OR 8:00-9:00 pm ET.
Provided by
This activity is provided by Optum Health Education and Optum Health, Clinical Performance.
Commercial support
No commercial support was received for this activity.
Required hardware/software
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.
Target Audience
This activity is designed to meet the educational needs of physicians, PAs, nurses, nurse practitioners, and other HCPs who have an interest in learning about active surveillance and management of prostate cancer.
Learning Objectives
At the end of this activity, participants should be able to:
- Describe the natural history of early-stage prostate cancer.
- Identify the benefits and drawbacks of screening for early-stage prostate cancer and associated diagnostic considerations.
- Discuss evidence-based active surveillance strategies for detection of early-stage prostate cancer.
Additional Information
Moderator
Joshua Jacobs, MD, FAAFP
National Medical Director
Optum Health
Presenter
Scott E. Eggener, MD
Bruce and Beth White Family Professor of Surgery (Urologic Oncology), Vice-Chair of Urology
Director of High Risk and Advanced Prostate Cancer Clinic
University of Chicago
About the presenter
Scott Eggener, MD, is a urologic oncologist at the University of Chicago. His research — which has resulted in over 300 publications — exclusively focuses on urologic cancers and primarily focuses on improving the screening, imaging, and management of men with prostate cancer. He is currently the associate editor (prostate cancer) for the Journal of Urology, on the executive board of International Volunteers in Urology and has chaired or participated in multiple ASCO/AUA prostate cancer guideline panels.
Activity planners
Elizabeth Albert, MD
Clinical Activity Manager
Optum Health Education
Sarah Chart, RN
Vice President
Optum Health Education
Joshua Jacobs, MD, FAAFP
National Medical Director
Optum Health
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Optum Health Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.
Dr. Eggener has disclosed that he is a consultant for and serves on the advisory board of Francis Medical, Profound Medical, Janssen Pharmaceuticals, Insightech and Candel Therapeutics.
The remaining activity faculty and planners have no financial relationships to disclose.
Accreditation statement
In support of improving patient care, this activity has been planned and implemented by Optum Health Education and Optum Health, Clinical Performance. Optum Health Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.
Credit designation statements
Nurses
The participant will be awarded up to 1.00 contact hour(s) of credit for attendance and completion of supplemental materials.
Nurse practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
Physicians
Optum Health Education designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs
The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
Attendance
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been preapproved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization from which they wish to obtain credit.
Available Credit
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 Attendance - General Attendance
These materials are intended ONLY for those who attended the live webcast held on March 8, 2023 from 6:00-7:00 pm ET OR 8:00-9:00 pm ET.
You must be logged into your account to participate in this activity. Get started by clicking “Continue” and completing the “Evaluation”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of your activities can be found under “My Account,” “My Activities.”